[go: up one dir, main page]

FI20000692L - Nikotiinikoostumuksia ja menetelmiä niiden koostamiseksi - Google Patents

Nikotiinikoostumuksia ja menetelmiä niiden koostamiseksi Download PDF

Info

Publication number
FI20000692L
FI20000692L FI20000692A FI20000692A FI20000692L FI 20000692 L FI20000692 L FI 20000692L FI 20000692 A FI20000692 A FI 20000692A FI 20000692 A FI20000692 A FI 20000692A FI 20000692 L FI20000692 L FI 20000692L
Authority
FI
Finland
Prior art keywords
formulating
methods
nicotine compositions
nicotine
compositions
Prior art date
Application number
FI20000692A
Other languages
English (en)
Swedish (sv)
Other versions
FI20000692A7 (fi
Inventor
Sven Boerje Andersson
Stefan Jonn
Tomas Landh
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of FI20000692L publication Critical patent/FI20000692L/fi
Publication of FI20000692A7 publication Critical patent/FI20000692A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Dispersion Chemistry (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20000692A 1997-09-25 2000-03-24 Nikotiinikoostumuksia ja menetelmiä niiden koostamiseksi FI20000692A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703458A SE9703458D0 (sv) 1997-09-25 1997-09-25 Nicotine compositions and methods of formulation thereof
PCT/SE1998/001632 WO1999015171A1 (en) 1997-09-25 1998-09-15 Nicotine compositions and methods of formulation thereof

Publications (2)

Publication Number Publication Date
FI20000692L true FI20000692L (fi) 2000-03-24
FI20000692A7 FI20000692A7 (fi) 2000-03-24

Family

ID=20408364

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000692A FI20000692A7 (fi) 1997-09-25 2000-03-24 Nikotiinikoostumuksia ja menetelmiä niiden koostamiseksi

Country Status (22)

Country Link
EP (1) EP1023069B1 (fi)
JP (1) JP2001517624A (fi)
KR (1) KR20010024305A (fi)
CN (1) CN1123343C (fi)
AT (1) ATE253362T1 (fi)
AU (1) AU733619B2 (fi)
BR (1) BR9815395A (fi)
CA (1) CA2304042A1 (fi)
DE (1) DE69819548T2 (fi)
DK (1) DK1023069T3 (fi)
EE (1) EE200000154A (fi)
ES (1) ES2210817T3 (fi)
FI (1) FI20000692A7 (fi)
HU (1) HUP0004802A3 (fi)
MX (1) MXPA00002955A (fi)
NO (1) NO20001540L (fi)
NZ (1) NZ503408A (fi)
PT (1) PT1023069E (fi)
RU (1) RU2201747C2 (fi)
SE (1) SE9703458D0 (fi)
WO (1) WO1999015171A1 (fi)
ZA (1) ZA988794B (fi)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US8256433B2 (en) 1999-07-16 2012-09-04 Aradigm Corporation Systems and methods for effecting cessation of tobacco use
US6799576B2 (en) 1999-07-16 2004-10-05 Aradigm Corporation System for effecting smoking cessation
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
KR100381622B1 (ko) * 2000-08-30 2003-04-26 디디에스텍주식회사 자극성을 줄인 염기성 약물의 구강 투여 조성물
DE10057769A1 (de) * 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
WO2003082240A1 (de) * 2002-03-30 2003-10-09 Beisel Guenther Zubereitung enthaltend fettsäure zur appetitminderung, sättigung und/oder gewichtsreduktion
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
KR100443722B1 (ko) * 2002-09-26 2004-08-09 이용원 니코틴을 함유한 하드츄잉캔디 및 그의 제조방법
ES2708552T3 (es) 2002-12-20 2019-04-10 Niconovum Ab Método para la preparación de un material particulado que contiene nicotina con una celulosa cristalina (en particular MCC)
FR2851470B1 (fr) * 2003-02-20 2007-11-16 Besins Int Belgique Composition pharmaceutique pour administration transdermique ou transmuqueuse
US10172810B2 (en) 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
WO2004075877A1 (en) * 2003-02-24 2004-09-10 Pharmaceutical Productions, Inc. Transmucosal drug delivery system
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
RU2250052C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
RU2250057C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
RU2250051C2 (ru) * 2003-05-16 2005-04-20 Квасенков Олег Иванович Способ производства некурительного табачного изделия
PL1648421T3 (pl) * 2003-07-24 2018-03-30 Glaxosmithkline Llc Folie rozpuszczające się w jamie ustnej
GB0322033D0 (en) * 2003-09-19 2003-10-22 Camurus Ab Composition
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US7125954B2 (en) 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
US20100247653A1 (en) * 2006-04-11 2010-09-30 Hans Lautenschlager Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
US20080287507A1 (en) * 2007-05-16 2008-11-20 John Hedenstrom Nicotine containing toiletry waters
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
GB2476471A (en) * 2009-12-22 2011-06-29 Norwich Pharma Technologies Ltd Cotinine formulation for the treatment of obesity
US8846725B2 (en) * 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
CN102552405B (zh) * 2012-03-21 2013-10-16 张伟 一种肛周术后麻醉镇痛的药物组合物的制备方法
CN103040741B (zh) * 2012-12-11 2014-11-05 中山大学 溶致液晶的前体混悬液及其制备方法
EP2964190A1 (en) * 2013-03-07 2016-01-13 Danmarks Tekniske Universitet Nano-microdelivery systems for oromucosal delivery of an active ingredient
CA3208137A1 (en) * 2013-05-06 2014-11-13 Juul Labs, Inc. Nicotine salt formulations for aerosol devices and methods thereof
WO2015090337A1 (en) * 2013-12-20 2015-06-25 Fertin Pharma A/S Nicotine powder composition
KR20170003926A (ko) * 2014-04-08 2017-01-10 산사 코포레이션 (바베이도스) 인코포레이티드 니코틴 제형 및 이의 제조방법
GB201414919D0 (en) * 2014-08-21 2014-10-08 Corbitt Terence Simon Formulations for transmucosal delivery
JP6882303B2 (ja) * 2016-01-13 2021-06-02 エルジー ハウスホールド アンド ヘルスケア リミテッド 口腔用製剤
CN108323791B (zh) * 2018-01-03 2021-02-12 云南中烟工业有限责任公司 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品
US20210145818A1 (en) * 2018-04-16 2021-05-20 Poviva Tea, Llc Compositions infused with nicotine compounds and methods of use thereof
CN109125251B (zh) * 2018-09-10 2021-08-13 武汉百纳礼康生物制药有限公司 一种包载蛋白类药物的温敏性液晶凝胶制剂及其制备方法
KR102186704B1 (ko) * 2019-02-18 2020-12-04 (주)아이엠디팜 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물
LU101511B1 (en) * 2019-12-02 2021-06-04 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance
LU101520B1 (en) * 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication
US12137723B2 (en) 2019-12-09 2024-11-12 Nicoventures Trading Limited Oral products with active ingredient combinations
NL2031331B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of a short-acting psychedelic compound
NL2031332B1 (en) 2022-03-18 2023-09-29 Plethora Therapeutics B V Transmucosal delivery of psychoactive compounds
EP4570082A1 (en) * 2023-12-15 2025-06-18 Contraf-Nicotex-Tobacco GmbH Oral product for delivery of nicotine comprising a nicotine salt of a fatty acid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
IL86170A (en) * 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US4908213A (en) * 1989-02-21 1990-03-13 Schering Corporation Transdermal delivery of nicotine
GB2230439A (en) * 1989-04-20 1990-10-24 Alec Stanley Walter Shaw Nicotine lozenges
US5531925A (en) * 1991-10-04 1996-07-02 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
JPH11513393A (ja) * 1995-10-12 1999-11-16 ジーエス ディベロップメント エービー 皮膚又は粘膜表面へのもしくは介する活性物質の投与用医薬組成物

Also Published As

Publication number Publication date
EP1023069A1 (en) 2000-08-02
NZ503408A (en) 2004-12-24
NO20001540D0 (no) 2000-03-24
ATE253362T1 (de) 2003-11-15
AU9287298A (en) 1999-04-12
JP2001517624A (ja) 2001-10-09
HUP0004802A3 (en) 2001-12-28
EP1023069B1 (en) 2003-11-05
EE200000154A (et) 2001-02-15
AU733619B2 (en) 2001-05-17
ES2210817T3 (es) 2004-07-01
DK1023069T3 (da) 2004-03-08
FI20000692A7 (fi) 2000-03-24
BR9815395A (pt) 2000-11-14
DE69819548T2 (de) 2004-08-12
PT1023069E (pt) 2004-02-27
NO20001540L (no) 2000-05-25
ZA988794B (en) 1999-04-01
RU2201747C2 (ru) 2003-04-10
CA2304042A1 (en) 1999-04-01
MXPA00002955A (es) 2002-04-24
CN1123343C (zh) 2003-10-08
SE9703458D0 (sv) 1997-09-25
CN1278174A (zh) 2000-12-27
KR20010024305A (ko) 2001-03-26
DE69819548D1 (de) 2003-12-11
WO1999015171A1 (en) 1999-04-01
HUP0004802A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
FI20000692L (fi) Nikotiinikoostumuksia ja menetelmiä niiden koostamiseksi
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
FI963692L (fi) Menetelmiä ja koostumuksia, jotka ovat käyttökelpoisia angiogeneesin inhibointiin
FI970522L (fi) Koostumukset ja menetelmät pidennetyn paikallisanestesian aikaansaamiseksi
EE03680B1 (et) Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
ID20233A (id) Komposisi oral
FI960889A7 (fi) Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä
EE9700138A (et) Aerosoolravimvormid
ID19097A (id) Komposisi-komposisi oral
FI951468A7 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
ID21762A (id) Formulasi partikel bersaput
FI990134L (fi) Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina
FI972308A7 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä si sältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
ID20466A (id) Komposisi oral
FI972988L (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI972306L (fi) Substituoituja 2-aryylikarbonyylioksimetyyli-1,2,5-tiadiatsolidin -3- oni-1,1-dioksidi-johdannaisia ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
FI943294L (fi) Alkaloidit Mappia foetidasta, niiden käyttö, ja niitä sisältävät formulloinnit
DE69708418D1 (de) Naphthylverbindungen und Zusammensetzungen
FI952738L (fi) Stabiiliproteiini, fosfolipidikoostumuksia ja menetelmiä
FI971462L (fi) Bentsisoksatsolijohdannaisia ja niitä sisältäviä torjuntaainekoostumuksia
ID19099A (id) Komposisi oral

Legal Events

Date Code Title Description
MA Patent expired